Abstract
Antibodies to the mycobacterial surface lipoglycan lipoarabinomannan (LAM) and its related capsular polysaccharide arabinomannan (AM) are increasingly important for investigations focused on both understanding mechanisms of protection against Mycobacterium tuberculosis (Mtb) and developing next-generation point-of-care tuberculosis (TB) diagnostics. We provide here an overview of the growing pipeline of monoclonal antibodies (mAbs) to LAM/AM. Old and new methodologies for their generation are reviewed and we outline and discuss their glycan epitope specificity and other features with implications for the TB field.
Original language | English (US) |
---|---|
Pages (from-to) | 22-35 |
Number of pages | 14 |
Journal | Trends in Microbiology |
Volume | 31 |
Issue number | 1 |
DOIs | |
State | Published - Jan 2023 |
Keywords
- antigen–antibody interactions
- biomarker
- glycans
- lipoglycans
- mycobacteria
- oligosaccharides
- point-of-care tests
ASJC Scopus subject areas
- Microbiology
- Microbiology (medical)
- Infectious Diseases
- Virology